Johnson & Johnson To Defend Baby-Powder Lawsuits In Court: Report
The controversial Johnson & Johnson (NYSE: JNJ) bankruptcy strategy will face a fresh trial to urge a judge to allow it to use the bankruptcy process to
Benzinga’s Daily Brief On Trending Tickers For Feb. 11, 2022: Cassava Sciences, Cleveland Cliffs, GameStop, and More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.
The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.
6 Companies That Recently Announced Large Buybacks
There are several ways that a company can return wealth to its shareholders. Price appreciation and dividends are the two most common ways, but there are other ways a company can introduce returns to buyers. One method that is less common, or overlooked, is share buybacks.
Amazon’s Telehealth Service Launches Nationwide Amid Increasing Demand
Amazon.com Inc (NASDAQ: AMZN) announced Tuesday that it's taking its telehealth service, Amazon Care, nationwide.
FDA Asks Pfizer – BioNTech To Submit For COVID-19 Vaccine Emergency Use Nod For Youngest Children
Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) have
Boston Scientific’s Q4 Earnings Slightly Above Consensus, FY22 Outlook Lag Estimates
Boston Scientific Corp (NYSE: BSX) generated
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
Novartis AG (NYSE: NVS) reported a Q4 net income of $16.31 billion, up from $2.1 billion the previous year,
Gilead Q4 Earnings Highlights: Remdesivir Sales Fall 30%, Raises Dividend, FY22 EPS Below Estimates
Gilead Sciences Inc (NASDAQ: GILD) posted